Terms: = Prostate cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Clinical Outcome
10 results:
1. Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostate.
Borkowetz A; Froehner M; Rauner M; Conrad S; Erdmann K; Mayr T; Datta K; Hofbauer LC; Baretton GB; Wirth M; Fuessel S; Toma M; Muders MH
Int J Cancer; 2020 May; 146(9):2619-2627. PubMed ID: 31509606
[TBL] [Abstract] [Full Text] [Related]
2. A rare case of extremely high counts of circulating tumor cells detected in a patient with an oral squamous cell carcinoma.
Wu X; Mastronicola R; Tu Q; Faure GC; De Carvalho Bittencourt M; Dolivet G
BMC Cancer; 2016 Jul; 16():552. PubMed ID: 27465596
[TBL] [Abstract] [Full Text] [Related]
3. Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients.
Gu CY; Qin XJ; Qu YY; Zhu Y; Wan FN; Zhang GM; Sun LJ; Zhu Y; Ye DW
Medicine (Baltimore); 2016 Jul; 95(27):e4066. PubMed ID: 27399092
[TBL] [Abstract] [Full Text] [Related]
4. High Absolute Monocyte Count Predicts Poor clinical outcome in Patients with Castration-Resistant prostate cancer Treated with Docetaxel Chemotherapy.
Shigeta K; Kosaka T; Kitano S; Yasumizu Y; Miyazaki Y; Mizuno R; Shinojima T; Kikuchi E; Miyajima A; Tanoguchi H; Hasegawa S; Oya M
Ann Surg Oncol; 2016 Nov; 23(12):4115-4122. PubMed ID: 27364499
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal prostate cancer.
Mehra R; Udager AM; Ahearn TU; Cao X; Feng FY; Loda M; Petimar JS; Kantoff P; Mucci LA; Chinnaiyan AM
Eur Urol; 2016 Oct; 70(4):549-552. PubMed ID: 26724257
[TBL] [Abstract] [Full Text] [Related]
6. Lymphoceles Post-Radical Retropubic prostatectomy: A Retrospective Evaluation of Epidemiology, Risk Factors and outcome.
Heers H; Laumeier T; Olbert PJ; Hofmann R; Hegele A
Urol Int; 2015; 95(4):400-5. PubMed ID: 25871980
[TBL] [Abstract] [Full Text] [Related]
7. Phase 2 study of sorafenib in malignant mesothelioma previously treated with platinum-containing chemotherapy.
Papa S; Popat S; Shah R; Prevost AT; Lal R; McLennan B; Cane P; Lang-Lazdunski L; Viney Z; Dunn JT; Barrington S; Landau D; Spicer J
J Thorac Oncol; 2013 Jun; 8(6):783-7. PubMed ID: 23571475
[TBL] [Abstract] [Full Text] [Related]
8. Correlation of power Doppler with microvessel density in assessing prostate needle biopsy.
Wilson NM; Masoud AM; Barsoum HB; Refaat MM; Moustafa MI; Kamal TA
Clin Radiol; 2004 Oct; 59(10):946-50. PubMed ID: 15451357
[TBL] [Abstract] [Full Text] [Related]
9. Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer.
Harris KA; Weinberg V; Bok RA; Kakefuda M; Small EJ
J Urol; 2002 Aug; 168(2):542-5. PubMed ID: 12131305
[TBL] [Abstract] [Full Text] [Related]
10. Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy.
Sartor CI; Strawderman MH; Lin XH; Kish KE; McLaughlin PW; Sandler HM
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):941-7. PubMed ID: 9276358
[TBL] [Abstract] [Full Text] [Related]
